Project Details
Description
A Phase 1 Study of AC220 (ASP2689) as Maintenance Therapy in Subjects With Acute Myeloid Leukemia Who Have Been Treated With an Allogeneic Hematopoietic Stem Cell Transplant
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/12 → 9/30/17 |
Funding
- ASTELLAS PHARMA US, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.